In Vivo Administration of a Nuclear Transcription Factor-κB Decoy Suppresses Experimental Crescentic Glomerulonephritis
Naruya Tomita(M4 Engineering (United States)), Toshio Ogihara(Osaka University), David J. Nikolic‐Paterson(Monash Medical Centre), Hui Y. Lan(Zhejiang Pharmaceutical College), Kei Yamamoto, Buichi Fujitani(Sumitomo Dainippon Pharma (Japan)), Kaoru Toyosawa(Sumitomo Dainippon Pharma (Japan)), Mitsue Notake(Sumitomo Dainippon Pharma (Japan)), Wei Mu(Tongji Hospital), Yasufumi Kaneda(Osaka University), Robert C. Atkins(Baker Heart and Diabetes Institute), Ryuichi Morishita(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Masahide Hashizume(Sumitomo Dainippon Pharma (Japan))
Cited by 114
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2
|Hypertension|2003|790
TGF-β/Smad signaling in renal fibrosis
|Frontiers in Physiology|2015|648